JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
-
Karyopharm Therapeutics Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Karyopharm Therapeutics Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Karyopharm Therapeutics (KPTI) Prices 9.15M Share Common Offering at $14.75/Sh
-
Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock
-
Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock
-
Karyopharm Therapeutics (KPTI) Commences $125M Common Stock Offering
-
Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock
-
Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock
-
Karyopharm Therapeutics to Participate in Upcoming Investor Conferences
-
Karyopharm to Present at the 2016 JMP Securities Life Science Conference
-
Karyopharm Therapeutics (KPTI) Prices 3M Common Offering at $33/Share
-
Karyopharm Therapeutics (KPTI) Reports 3M Share Stock Offering
-
Karyopharm Therapeutics (KPTI) Announces 2.95M Common Offering
-
Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock
-
Pre-Open Stock Movers 10/07: (GSAT) (BCLI) (GTAT) Higher; (CBK) (SODA) (TCS) Lower (more...)
-
Karyopharm Therapeutics (KPTI) Prices Upsized 2.65M Common Offering at $42.50/Share
-
Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock
-
Karyopharm Therapeutics (KPTI) Commences 2.2M Common Stock Offering
-
Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock
-
Karyopharm Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares in Its Initial Public Offering
-
JMP Securities Starts Karyopharm Therapeutics (KPTI) at Market Outperform
-
Karyopharm Therapeutics (KPTI) IPO Opens Higher

